ACTRN12614000080628Recruiting未知
Study of heart failure outcomes in stage A heart failure patients screened using advanced echocardiography techniques.
Menzies Research Institute Tasmania0 sites800 target enrollmentStarted: January 22, 2014Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 800
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomised controlled trial
- Primary Purpose
- Diagnosis
- Masking
- Blinded (masking used)
Eligibility Criteria
- Ages
- 65 Years to o limit (—)
- Sex
- All
Inclusion Criteria
- •Aged >65 years with one or more of the following;
- •- diabetes (T2DM)
- •- high blood pressure
- •- past cancer chemotherapy
- •- F/H of heart failure
- •- known cardiac disease (but not existing heart failure)
Exclusion Criteria
- •- Unable to provide written informed consent to participate in this study
- •- Participating in another clinical research trial where randomized treatment would be unacceptable
- •- History of >moderate valvular heart disease
- •- History of previous heart failure
- •- Existing medical therapy with beta blockers and ACE inhibitors
- •- Contraindications/Intolerance to beta blockers or ACE inhibitors
- •- Systolic BP <110mmHg
- •- Pulse <60/minute
- •- Baseline NYHA >2
- •- Oncologic life expectancy < 12 months
- •- Inability to acquire interpretable images (identified from baseline echo)
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Investigation of the effects of heart failure with preserved ejection fraction (HFpEF) on cerebral small vessel diseaseHeart failure with preserved ejection fraction (HFpEF)DRKS00031583niversitätsklinikum Magdeburg102
Recruiting
Not Applicable
Survey on the occurrence of heart failure after administration of TARLIGE -MID-NET Cohort Studyeuropathic painJPRN-jRCT2031220177Matsuoka for Yomei24,000
Active, not recruiting
Not Applicable
Survival of patients with acute heart failure in need of intravenous inotropic support; a multicentre parallel- group, randomised, double- blind, double- dummy study of levosimendan versus dobutamine in patients with acute heart failure. - The SURVIVE studyEUCTR2004-001225-16-ATOrion Pharma700
Recruiting
Not Applicable
Predictors of outcome in heart failure with preserved ejection fractioI50.19I27.28DRKS00004573Medizinische Universität Wien, Allgemeines Krankenhaus der Stadt Wien, Universitätsklinik II für Innere Medizin , Abteilung für Kardiologie350
Completed
Not Applicable
Early recognition of heart failure in patients with diabetes type 2 in primary care.heart failure1001928010018424NL-OMON32109niversitair Medisch Centrum Utrecht600